Circassia Ends AZ Deal To Dig Itself Out Of Debt Hole

Only Diagnostics Business Remains

Circassia is returning the US rights to two COPD drugs to AstraZeneca as it admits it cannot meet its debt payments from the deal.    

Hand man doing finances and calculate on desk about cost at home office.
• Source: Shutterstock

More from Business

More from Scrip